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Abstract
The present study investigated the effects of transcutaneous vagus nerve stimulation on car-
diac vagal activity, the activity of the vagus nerve regulating cardiac functioning. We applied
stimulation on the left cymba conchae and tested the effects of different stimulation intensities
on a vagally-mediated heart rate variability parameter (i.e., the root mean square of succes-
sive differences) as well as on subjective ratings of strength of perceived stimulation intensity
and unpleasantness due to the stimulation. Three experiments (within-subject designs, M =
61 healthy participants each) were carried out: In Experiment 1, to choose one fixed stimula-
tion intensity for the subsequent studies, we compared three preset stimulation intensities
(i.e., 0.5, 1.0 and 1.5 mA) with each other. In Experiment 2, we compared the set stimulation
method with the free stimulation method, in which the participants were instructed to freely
choose an intensity. In Experiment 3, to control for placebo effects, we compared both meth-
ods (i.e., set stimulation vs. free stimulation) with their respective sham stimulations. In the
three experiments, an increase of cardiac vagal activity was found from resting to the stimula-
tion phases. However, this increase in cardiac vagal activity was not dependent on stimula-
tion intensity (Experiment 1), the method used to stimulate (i.e., set vs. free; Experiment 2),
or whether stimulation was active or sham (Experiment 3). This pattern of results was solidly
supported by Bayesian estimations. On the subjective level, higher stimulation intensities
were perceived as significantly stronger and a stronger stimulation was generally also per-
ceived as more unpleasant. The results suggest that cardiac vagal activity may be similarly
influenced by afferent vagal stimuli triggered by active and sham stimulation with different
stimulation intensities. Potential explanations for these findings and its implications for future
research with tVNS are discussed.
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Introduction
Transcutaneous vagus nerve stimulation (tVNS) is a noninvasive technology used to electri-
cally modulate vagal activity and consequently brain activity via afferent vagal pathways [1].
Because of its safety and the absence of major side effects [1,2], tVNS has been applied in both
research and therapy as a medical treatment tool. In recent years, this research field has seen a
noteworthy growth through studies investigating how tVNS positively affects cognitive [3],
affective [4], and neurophysiological [5] processes. However, because of the novelty of this
technology and the absence of standards regarding stimulation protocol, the tVNS-related
stimulation parameters have not been used consistently in research [6], which impedes the
comparability of such studies. Thus, understanding both the action mechanism of this neuro-
modulation tool and the processes yielded by the stimulation seems to be crucial. The present
work addressed this issue with a focus on stimulation intensity, also known as amplitude, as a
changeable stimulation parameter across three experiments and investigated the influence of
tVNS on a psychophysiological marker, heart rate variability (HRV).
Essentially, tVNS acts on the afferent auricular branch of the vagus nerve through elec-
trodes placed on the skin of the left ear. Its placement allows for a sham stimulation, which has
the same characteristics as normal tVNS, but instead of the electrodes being attached to the
cymba conchae, they are attached to the earlobe. The earlobe is thought to be free of vagal
innervation [7]. The tVNS’ mechanism of action can be explained by considering the neuroan-
atomical pathways of the vagus nerve. The electrical signal, starting in the auricular branch of
the vagus nerve, reaches the nucleus tractus solitarius, which is a crucial structure that projects
to a variety of brain areas, for instance the locus coeruleus [1]. Locus coeruleus is the primary
source of norepinephrine in the brain [8]. The noradrenergic supply includes cortical regions
such as the anterior cingulate cortex and the prefrontal cortex [9]. An increase in prefrontal
activity leads to an increase in parasympathetic nervous system activity and to a decrease in
sympathetic activity, since the prefrontal cortex is thought to exert a tonic inhibitory control
on the sympathetic nervous system [10]. According to the neurovisceral integration model
[11], the prefrontal cortex controls cardiac vagal activity, the activity of the vagus nerve regu-
lating cardiac functioning [12], via top-down mechanisms, and is thought to be also positively
linked to cognitive processes such as executive functioning [11]. Consequently, higher cardiac
vagal activity is linked to the optimal activation of neural networks underlying the effectiveness
of prefrontal activity [10]. Given this regulatory role of the prefrontal cortex on cardiac vagal
activity and that the tVNS signal is sent afferently to the prefrontal cortex via the auricular
branch of the vagus nerve, cardiac vagal activity may be affected by tVNS [13]. It has been dis-
cussed that tVNS targets three neurotransmitters, namely, norepinephrine, gamma-aminobu-
tyric acid, and acetylcholine, which are thought to be directly involved in cognitive
functioning [14]. As mentioned above, an increase in cardiac vagal activity can indicate that
tVNS, when applied on the left auricular branch of the vagus nerve, is afferently sending a sig-
nal to the prefrontal cortex, therefore positively affecting cognitive functioning. Thus, measur-
ing cardiac vagal activity during tVNS may lead to a better understanding of the physiological
pathways behind specific cognitive processes.
An array of studies using tVNS performs electrode placement on the left side of the ear in
order to control for cardiac side effects [3,15–20]. This is based on previous research stating
that efferent vagal fibers to the heart are located on the right side, whereas the left vagus nerve
mainly consists of afferent vagal fibers [21]. Since the present study aims at addressing the
effect of tVNS on cardiac vagal activity through the pathway explained previously and not by
pathways to which the prefrontal cortex seems to be less related, we performed the stimulation
on the left ear.
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In contrast to sham stimulation, tVNS produces a significant activation of central vagal pro-
jections, as shown by functional magnetic resonance imaging (fMRI) studies [16,22–25] of, for
example, the nucleus tractus solitarius [16,24] and the locus coeruleus, [23,25] as well as the
left prefrontal cortex and cingulate areas [22]. However, these studies used very different stim-
ulation parameters, for example, differing in electrode placement areas on the ear, pulse width,
frequency, and on–off cycle. Possibly because of the use of different stimulation parameters,
these studies had heterogeneous results, with different brain areas being found to be related to
tVNS [22]. Using HRV-related parameters to measure autonomic balance, Clancy and col-
leagues [26] showed that tVNS can increase parasympathetic activity and simultaneously sup-
press sympathetic activity. However, this positive effect of tVNS on vagally related HRV could
not be clearly shown in other studies [4,27–29]. These contradictory results might be, again,
due to the use of different stimulation parameters in these studies, for instance, the use of dif-
ferent devices and consequently different positioning of the electrodes on the ear, resulting in
a lack of comparability across results. Varying stimulation intensities might have also played a
role in these divergent findings.
Given the substantial heterogeneity in tVNS literature regarding choice of stimulation
parameters, the lack of knowledge about optimal stimulation parameters can be seen as a gen-
eral limitation in this field [4,22,26]. Likewise, the consideration of certain HRV parameters to
measure the effects of tVNS on cardiac activity may render their interpretation difficult. For
instance, Clancy [26] showed that tVNS can evoke a decrease in the ratio between low and
high frequencies of HRV (LF/HF), with this result being interpreted as a shift in cardiac auto-
nomic function toward parasympathetic dominance. However, it is noteworthy that the role of
this HRV parameter in depicting sympathovagal balance has recently been discarded, so no
real physiological conclusion can be drawn from this finding [30]. Recently, Badran and col-
leagues [6] systematically tested the effect of variations in pulse width and frequency on heart
rate and found that a pulse width of 500 μs, if combined with a frequency of 10 Hz, provoked
the strongest decrease in heart rate compared to other parameter combinations. Nonetheless,
heart rate represents the result of mixed inputs from the sympathetic and parasympathetic
(vagus) nerves [31,32]. Thus, this finding cannot be linked specifically to cardiac vagal activity.
Consequently, investigating the effect of tVNS parameters on valid indicators of cardiac vagal
activity remains a research gap to be filled [33].
Stimulation intensity, also known as amplitude, varies highly by experimental protocol in
tVNS studies. This parameter is also the only one that can be changed in the presently most
commonly used tVNS device in cognitive research, NEMOS by Cerbomed (Erlangen, Ger-
many). To date, there is no standard protocol for tVNS to systematically set this parameter.
Two main methods have been identified in the literature to set stimulation intensity: what we
call the set stimulation method and the free stimulation method. In the set stimulation method,
the stimulation intensity is determined by the experimenters beforehand and therefore does
not vary individually across the experiment. The predetermined intensity has often been set at
0.5 mA [3,20,34], and the choice of this intensity is justified as being recommended by another
study [23]. However, no mention of 0.5 mA could be found in this original work. In the free
stimulation method, participants are instructed to freely choose the highest subjectively com-
fortable stimulation intensity below the discomfort threshold [17,18,27,35].
The effects of tVNS are thought to exhibit an inverted U-shaped relationship concerning
stimulation intensity, so that, similar to the Yerkes–Dodson principle [36], an intermediate
stimulation intensity provokes the strongest effect [1,14]. One explanation for this pattern is
that a low stimulation intensity may not be enough to activate the afferent vagal pathway,
whereas a high stimulation intensity can cause discomfort. Discomfort is thought to negatively
impact HRV parameters [37]. Another possible explanation is that participants experience
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control over the stimulation intensity in the free compared to the set stimulation method. Feel-
ings of increased control can affect anxiety and pain, as well as the willingness to tolerate dis-
comfort. Although there is evidence of this inverted U-shaped relationship for invasive
(cervical) VNS regarding memory retention [38] and cortical plasticity [39], there is still a lack
of evidence for tVNS regarding cardiac regulation, making this idea merely speculative for car-
diac vagal activity. Insights on this potentially existing inverted U-shaped relationship for
tVNS with its expected outcomes could be important for optimizing its effects and eventually
for improving safety. Therefore, the existence of the inverted U-shaped relationship should be
further investigated [1,14].
In summary, discrepancies appear in the literature regarding tVNS stimulation intensity.
The present study goes beyond existing research on tVNS by focusing on this issue and sys-
tematically testing different stimulation intensity settings for tVNS and their effects on cardiac
vagal activity, as measured using HRV parameters, addressing both set and free stimulation
methods for determining stimulation intensity. The objectives of the present work were three-
fold: first, to investigate the effects of tVNS on cardiac vagal activity dependent on stimulation
intensity; second, to find the optimal way to choose a stimulation intensity that provokes the
strongest increase in cardiac vagal activity; and third, to examine the differences in how stimu-
lation methods are subjectively rated in terms of perceived strength and (un)pleasantness. To
answer these questions, we designed three experiments that addressed different stimulation
intensities as well as different methods to determine stimulation intensity. Across all three
experiments, (H1) we expected cardiac vagal activity to increase during tVNS compared to
baseline measurements. Specifically, for Experiment 1 we hypothesized (H2) that when using
the set stimulation method, the intermediate stimulation intensity would increase cardiac
vagal activity more than both the weaker and the stronger stimulation intensity, in accordance
with the Yerkes–Dodson principle [36]. For Experiments 2 and 3, we expected (H3) the free
stimulation method to evoke a higher increase in cardiac vagal activity compared to the set
stimulation method, given that an unpleasant stimulation intensity can be better avoided by
means of a subjectively more suitable self-chosen intensity. Finally, for Experiment 3, we
expected (H4) tVNS to provoke higher cardiac vagal activity compared to sham stimulation.
General method
We conducted three single-blind experiments with a within-subject design, as recommended
by Quintana and Heathers [40], to address the high interindividual variation and the complex
interactions influencing HRV. Aiming at choosing one fixed stimulation intensity to be used
in Experiments 2 and 3, in Experiment 1 we focused on three different fixed stimulation inten-
sities, allowing us to explore the set stimulation method and its effects on cardiac vagal activity.
In Experiment 2, focusing on the two most common methods to determine stimulation inten-
sity in tVNS research, we compared the set stimulation method with the free stimulation
method regarding their effect on cardiac vagal activity. To shorten the experiments’ length and
to avoid an eventual positive effect of habituation on cardiac vagal activity, both Experiments 1
and 2 were done without a sham condition. In Experiment 3, to control for confounding
effects such as a placebo effect, we compared both methods with their respective sham stimula-
tions regarding cardiac vagal activity.
Participants
An a priori G�Power calculation [41] was carried out to estimate the sample size required for
the three experiments. On the basis of previously published [26] recalculated effect sizes of the
LF/HF ratio, we expected small to medium effect sizes for the effects of tVNS on HRV. The
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calculation for a repeated measure analysis of variance (ANOVA) with within-subject factors, f
= .17, α = .05, power = .80, estimated that 60 participants were required for each experiment.
Anticipating possible exclusions after data cleaning, we recruited on average 65 participants
for each study.
The sample consisted of healthy sport science students at the local university. Participants
were eligible if they were free of cardiovascular or neurological diseases or major mental condi-
tions and were not pregnant at the time of the experiment. They were asked not to smoke,
exercise, or consume food, alcohol, or caffeine for at least 2 h before participation. These
potentially confounding variables as well as tVNS safety-related questions were assessed by
means of an adapted version of the questionnaire for HRV psychophysiological experiments
developed by Laborde et al. [33]. None of the participants had experienced tVNS prior to this
study. A new sample was tested in each experiment and participants gave written informed
consent prior to the experiment. All experiments were approved by the ethical committee of
the German Sport University Cologne (ethics approval numbers 158/2016, 078/2017 and 019/
2018, respectively).
Materials and methods
Transcutaneous vagus nerve stimulation. We employed the NEMOS tVNS device devel-
oped by Cerbomed (Erlangen, Germany), which was delivered with a pulse width of 200–
300 μs at 25 Hz and an on–off cycle of 30 s. Two titan electrodes located in a structure similar
to an earphone are placed on the cymba conchae of the left ear, an area thought to be exclu-
sively innervated by the auricular branch of the vagus nerve [24].
Cardiac vagal activity. To assess cardiac vagal activity, we used the Faros 180˚ device
from Mega Electronics (Kuopio, Finland) with a set sampling rate of 500 Hz. This device
enables users to measure the electrocardiogram (ECG) signal as recommended by guidelines
on HRV measurement [33]. We placed two disposable ECG pre-gelled electrodes (Ambu L-
00-S/25, Ambu GmbH, Bad Nauheim, Germany) on the body, the positive electrode on the
right infraclavicular fossa and the negative one on the left anterior axillary line below the 12th
rib.
The root mean square of successive differences (RMSSD) was chosen as indicator of cardiac
vagal activity in the main analyses, with an increase of RMSSD meaning an increased cardiac
vagal activity [12]. From ECG recordings we extracted HRV with Kubios software (University
of Eastern Finland, Kuopio, Finland), visually inspected the full ECG recording, and manually
removed artifacts [33]. Following recommendations for HRV measurement [12], we analyzed
measurements in blocks of 5 min.
Subjective stimulation perception. At the end of each stimulation on–off cycle, that is,
during 30-s breaks following 30-s stimulation units, the participants were instructed to answer
questions on a Likert scale of 0 to 9 that were explicitly related to the past 30-s stimulation. The
questions aimed at measuring perceived stimulation intensity and stimulation unpleasantness,
respectively, and are “how intense is the tingle in your ear?” (0 = I do not feel anything, 9 =
extremely strong) and “how pleasant or unpleasant is the sensation now?” (0 = very pleasant, 9
= very unpleasant).
Procedure
For each experiment, all participants underwent all stimulation conditions within one session
in a counterbalanced order, to cancel out order effects. The participants were randomly
assigned to the different possible order sequences. At the beginning of each experiment, a
tVNS familiarization took place. In this phase, the participants received tVNS with 0.1 mA at
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the beginning and were instructed to increase the stimulation intensity within 5 min until
reaching 1.0 mA. Following the familiarization period, HRV measurement was performed for
all conditions. Each condition was measured within a block that consisted of two sub-blocks:
The first one was performed to take resting cardiac vagal activity into account (5-min measur-
ing interval), and the second one to measure cardiac vagal activity during the stimulation
phase (10-min period, see Fig 1).
Data analysis
Outliers (less than 1% of the data) were Winsorized, meaning that values higher/lower than two
standard deviations from the mean were transformed into a value of two standard deviations
from the mean. Since the HRV data were afterwards still not normally distributed, they were
log-transformed to obtain a normal distribution, as is usually done in HRV research [33]. A
repeated measures ANOVA was conducted on RMSSD as a dependent variable and included
the independent variables time (resting, the first 5 min of the stimulation period (stimulation
first half), and the last 5 min of the stimulation period (stimulation second half) and condition
(stimulation intensities and stimulation methods or stimulation conditions, dependent on the
experiment) as within-subject factors. Greenhouse–Geisser correction was used when sphericity
was violated. In the case of a significant main or interaction effect, post hoc t-tests with aggre-
gated means were conducted using Bonferroni correction. To quantify evidence for the hypoth-
eses found, we ran Bayesian statistics using Bayesian information criteria [42] for the main
analysis of RMSSD. Terms used to discuss the reported Bayes factors are based on Wetzels and
colleagues’ recommendations [43] and have the following meanings: anecdotal or worth no
more than a bare mention (0.333< B10 < 3), substantial (0.100< B10� 0.333 or 3� B10 < 10),
strong (0.033< B10� 0.100 or 10< B10 < 30), very strong (0.010< B10� 0.033 or 30� B10 <
100), and decisive (B10� 0.010 or B10� 100) evidence. Additionally, a Friedman test was per-
formed for perceived intensity (mean) and for stimulation unpleasantness (mean) with condi-
tion (stimulation intensities or stimulation methods, dependent on the experiment) as a
Fig 1. Study protocols for all experiments.
https://doi.org/10.1371/journal.pone.0223848.g001
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nonnormally distributed within-subject factor, with Wilcoxon tests for post hoc analyses.
RMSSD was correlated using Spearman correlations with average perceived intensity and aver-
age stimulation unpleasantness, as well as average stimulation intensity during the free stimula-
tion and the free sham conditions. To control for carry-over effects on RMSSD which
potentially arose in the stimulation condition due to the previous stimulation condition, we
tested the effect of position (i.e., first, second and third resting blocks in Experiment 1, first and
second resting blocks in Experiment 2 and first, second, third and fourth resting blocks in
Experiment 3) in one-way repeated measures ANOVAs or a paired t-test (for Experiment 2).
Further, despite the fact that LF/HF and HR do not reflect clear physiological mechanisms
regarding the functioning of the autonomic nervous system [30,31,44], for reasons of compari-
son with previous studies addressing effects of tVNS on HRV parameters, we also carried out
three repeated measures MANOVA with RMSSD, LF/HF and HR as dependent variables. More
details and the analyses can be found as supporting information (S1 Text). We used IBM SPSS
Statistics 25 for data preparation and nonparametric analyses and JASP 0.9.1.0 to analyze the
data for repeated measures ANOVAs, correlations, t-tests and Bayesian statistics. Significance
level was α = .05.
Experiment 1
In Experiment 1, we investigated set stimulation intensity by comparing three previously
set stimulation intensities (0.5, 1.0, and 1.5 mA) with the aim of choosing one fixed stimula-
tion intensity to be used in Experiments 2 and 3. These stimulation intensities were chosen
following a previous study [38] on the effect of invasive cervical vagus nerve stimulation on
recognition memory in humans using 0.5, 0.75, and 1.5 mA as stimulation intensities. To
investigate the hypothesis related to the inverted U-shaped relationship with equal intervals,
facilitating the results interpretation, we changed the intermediate stimulation intensity to
1.0 mA.
Besides expecting cardiac vagal activity to increase during tVNS compared to baseline mea-
surements (H1), specifically for Experiment 1 we hypothesized (H2) that 1.0 mA would pro-
voke the highest cardiac vagal activity when compared to 0.5 and 1.5 mA. In addition, we
hypothesized (H2.1) that 1.5 mA would be perceived as the most uncomfortable stimulation
intensity among the three intensities we deployed. Therefore, both (H2.2) the perception of
stimulation intensity and (H2.3) the reported sensation of unpleasantness during 1.5-mA stim-
ulation would be associated with a decrease in RMSSD during this condition. After excluding
participants because of the excluding criteria and for technical issues during measurement, 61
participants were included in the data analysis (16 females, Mage = 23.32 years). We ran a
repeated measures ANOVA for RMSSD with time (resting, stimulation first half, and stimula-
tion second half) and stimulation intensity (0.5, 1.0 and 1.5 mA) as factors. For subjective rat-
ings, a Friedman test was run for perceived intensity (median) and for stimulation
unpleasantness (median) with condition (0.5, 1.0 and 1.5 mA) as a nonnormally distributed
within-subject factor, with Wilcoxon tests for post hoc analyses.
Results
Cardiac vagal activity. Descriptive statistics for RMSSD and for the subjective variables
are presented in Table 1 and results of the hypothesis testing can be found in Table 2. A
repeated measures ANOVA showed a main effect of measurement time for RMSSD, F(1.565,
93.900) = 8.590, p = .001, ηp2 = .125 (Fig 2). Three post hoc analyses were done, resulting in a p
value of .017 after Bonferroni correction. They pointed out a significant increase from resting
RMSSD (M = 54.81, SD = 26.86) to RMSSD during the first half of the stimulation period
Influence of transcutaneous vagus nerve stimulation intensity on cardiac vagal activity
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(M = 59.71, SD = 27.59), t(60) = 3.277, p = .002, d = 0.420, and no significant difference
between RMSSD during the first and during the second half of the stimulation (M = 58.01,
SD = 26.69), t(60) = 1.706, p = .093, or between resting RMSSD and RMSSD during the second
half of the stimulation period, t(60) = 2.134, p = .037. No significant main effect of stimulation
condition, F(2, 120) = 1.373, p = .257, or interaction effect of time × condition, F(3.507,
210.392) = 1.840, p = .131, for RMSSD was found. Because of the lack of a main effect of condi-
tion and the lack of an interaction between time and condition for RMSSD, we ran a Bayesian
repeated-measures ANOVA. According to the estimated Bayes factors (alternative/null), data
provided strong evidence against the alternative hypothesis for condition (B10 = 0.086) and for
the interaction effect between condition and time (B10 = 0.045).
Table 1. Descriptive statistics for Experiments 1, 2 and 3. Mean scores and standard deviations for the root mean square of successive differences (RMSSD) and median
values for perceived stimulation intensity and unpleasantness.
Experiment 1 Experiment 2 Experiment 3
0.5 mA 1.0 mA 1.5 mA Set
stimulation
Free
stimulation
Set active
stimulation
Set sham
stimulation
Free active
stimulation
Free sham
stimulation
RMSSD values
Resting RMSSD 54.94
(26.39)
56.87
(29.67)
55.01
(25.98)
43.02
(16.74)
43.85
(17.46)
62.70
(24.37)
62.12 (26.97) 60.75 (24.33) 61.01
(25.65)
Stimulation 1st half
RMSSD
59.89
(29.20)
60.27
(30.17)
58.99
(26.88)
45.79
(18.55)
48.54
(22.41)
63.18
(26.67)
64.87 (28.71) 63.50 (25.65) 63.61 (27.99)
Stimulation 2nd half
RMSSD
57.17
(26.78)
58.20
(29.27)
58.68
(26.16)
46.73
(18.37)
48.44
(20.01)
65.79 (29.05) 66.21 (30.76) 64.72
(27.32)
64.04 (27.46)
Subjective ratings
Perceived stimulation
intensity
1.66
(1.05)
3.40
(2.06)
5.15
(2.19)
3.76
(2.47)
6.44
(2.29)
1.77
(2.32)
1.96
(2.54)
6.50
(2.00)
6.22
(1.83)
Unpleasantness 2.03
(1.91)
3.32
(2.06)
4.69
(2.24)
4.89
(2.76)
5.19
(2.55)
1.46
(1.93)
1.98
(2.02)
3.94
(2.21)
3.13
(2.05)
https://doi.org/10.1371/journal.pone.0223848.t001
Table 2. Results of repeated measures analysis of variance for the root mean square of successive differences (RMSSD), with Bayesian analysis (B10) as well as post
hoc tests for time measurement and for the subjective variables (Experiment 1).
RMSSD F-value p-value ηp2 B10
Time measurements 8.590 .001 .125 11,559.067
Stimulation condition 1.373 .257 0.086
Time x condition 1.840 .131 0.045
Time measurements (RMSSD) t-value p-valuea Cohen’s d B10
Resting vs. stimulation 1st half 3.277 .002 .420 16.165
Stimulation 1st half vs. 2nd half 1.706 .093 0.548
Resting vs. stimulation 2nd half 2.134 .037 1.153
Perceived intensity z-value p-valuea r-value B10
0.5 vs. 1.0 mA 6.630 < .001 .600 2.190�1012
0.5 vs. 1.5 mA 6.630 < .001 .388 1.048�1017
1.0 vs. 1.5 mA 4.290 < .001 .600 360,314
Unpleasantness
0.5 vs. 1.0 mA 5.100 < .001 .461 1.245�106
0.5 vs. 1.5 mA 5.590 < .001 .381 1.622�109
1.0 vs. 1.5 mA 4.210 < .001 .506 36,515
aBonferroni-corrected p = .017.
https://doi.org/10.1371/journal.pone.0223848.t002
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Estimation of carry-over effects on RMSSD. A univariate repeated measures ANOVA
was performed to check if the position of the resting phases, namely the first (M = 54.92,
SD = 29.43), the second (M = 54.83, SD = 26.83) and the third resting phase (M = 55.94,
SD = 27.24), differed from each other regarding RMSSD. RMSSD during the different resting
phases did not differ significantly from each other, F(2, 120) = 0.70, p = .498.
Subjective responses. A Friedman test indicated that the ratings of the stimulation inten-
sities during the different stimulation conditions varied significantly across the different stim-
ulation conditions, χ2(2) = 87.790, p< .001. Three post hoc analyses were done, resulting in a
p value of .017 after Bonferroni correction. Post hoc Wilcoxon tests showed that the stimula-
tion intensity 0.5 mA (Mdn = 1.73) was perceived as significantly lower than both 1.0 mA
(Mdn = 3.24), z = 6.630, p< .001, r = .600, and 1.5 mA (Mdn = 4.856), z = 6.630, p< .001, r =
.388. The stimulation intensity 1.5 mA was perceived as significantly stronger than 1.0 mA,
z = 4.290, p< .001, r = .600.
In a similar vein, regarding unpleasantness, it was shown that the measures differed signifi-
cantly across stimulation conditions, χ2(2) = 48.970, p< .001. Post hoc analyses with Wilcoxon
tests (Bonferroni-corrected p = .017) indicated that the stimulation intensity 0.5 mA
(Mdn = 2.05) was rated as significantly less unpleasant than both 1.0 mA (Mdn = 3.20),
z = 5.100, p< .001, r = .461, and 1.5 mA (Mdn = 4.14), z = 5.590, p< .001, r = .381. The stimu-
lation intensity 1.5 mA was perceived as significantly more unpleasant than 1.0 mA, z = 4.210,
p< .001, r = .506. Moreover, perceived intensity correlated positively with RMSSD only dur-
ing the 1.5 mA condition, during all three phases: resting (r = .331, p = .009), reactivity (r =
Fig 2. Experiment 1. Mean scores of root mean square of successive differences (RMSSD). Scores during different stimulation intensities at three
time measurement points. Error bars represent confidence intervals (95%).
https://doi.org/10.1371/journal.pone.0223848.g002
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.256, p = .047), and recovery (r = .307, p = .016). Unpleasantness correlated with no RMSSD
measurements during stimulation.
Discussion of Experiment 1
The aim of Experiment 1 was to compare the effect of three different stimulation intensities on
physiological and subjective measurements. A significant increase of RMSSD during the stim-
ulation phase was found compared to the resting phases prior to stimulation. H1 was therefore
supported. However, this increase was general and thus not dependent on the different fixed
stimulation intensities. These results were solidly supported by Bayesian statistics. H2, which
was based on the Yerkes–Dodson principle [36], was therefore rejected. H2.1 was supported,
since 1.5 mA was perceived as the strongest and most uncomfortable stimulation intensity
among the three stimulation intensities. Finally, given that only perceived intensity correlated
with RMSSD during the 1.5 mA condition and that this correlation was positive, H2.2 and
H2.3 were rejected.
Experiment 2
In Experiment 2, we compared the set stimulation method with the free stimulation method,
in which the participants were instructed to freely choose a comfortable intensity just below
the discomfort level. Given the absence of a statistical difference between the three stimulation
intensities tested on cardiac vagal activity in Experiment 1, we chose the intermediate stimula-
tion intensity from Experiment 1, 1.0 mA, as stimulation intensity for the set stimulation
method in Experiment 2. Besides expecting cardiac vagal activity to increase during tVNS
compared to baseline measurements (H1), for the reasons already stated, we hypothesized
(H3) that the free stimulation method would evoke a higher increase in cardiac vagal activity
compared to the set stimulation method. Moreover, we expected (H3.1) the set stimulation
method, when compared to the free stimulation method, to be perceived as more uncomfort-
able method to set the stimulation intensity. Therefore, both (H3.2) the perception of stimula-
tion intensity and (H3.3) the reported sensation of unpleasantness during set stimulation
would be associated with a decrease in RMSSD during this condition.
The participants were aware of the chosen stimulation intensity over the course of the
experiment in the free stimulation condition and could freely change the intensity once at the
beginning of the on phases within the on–off cycles. After excluding participants because of
the excluding criteria, 62 participants took part in Experiment 2 (26 females, Mage = 24.77
years) and the average chosen stimulation intensity in the free stimulation method was M=
1.78 mA (SD = 1.13). We ran a repeated measures ANOVA for RMSSD with time (resting,
stimulation first half, and stimulation second half) and stimulation method (set stimulation
method and free stimulation method) as factors. For subjective ratings, a t-test was run for per-
ceived intensity (mean) and for stimulation unpleasantness (mean) with condition (set stimu-
lation method and free stimulation method) as a normally distributed within-subject factor.
Results
Cardiac vagal activity. Descriptive statistics for RMSSD and for the subjective variables
can be seen in Table 1 and results of the hypothesis testing can be found in Table 3. Regarding
RMSSD, we found a main effect of time, F(2, 122) = 15.354, p< .001, η2 = .206 (Fig 3). Three
post hoc analyses were done, with pairwise comparisons (Bonferroni-corrected p = .017)
showing a significant increase from resting RMSSD (M = 43.44, SD = 16.66) to RMSSD during
the first half of the stimulation period (M = 44.82, SD = 17.39), t(59) = 2.960, p = .004,
d = 0.382, and to RMSSD during the second half of the stimulation period (M = 45.29,
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Table 3. Results of repeated measures analysis of variance for the root mean square of successive differences (RMSSD), with Bayesian analysis (B10), post hoc tests
for time measurement and t-tests for the subjective variables (Experiment 2).
RMSSD F-value p-value ηp2 B10
Time measurements 15.354 < .001 0.206 1,777.357
Stimulation condition 1.715 .195 0.129
Time x condition 0.419 .888 0.060
Time measurements (RMSSD) t-value p-valuea Cohen’s d B10
Resting vs. stimulation 1st half 2.960 .004 0.382 7.138
Stimulation 1st half vs. 2nd half 3.410 < .001 0.333 0.214
Resting vs. stimulation 2nd half 0.935 .354 23.136
Perceived intensity t-value p-valuea Cohen’s d B10
Set stimulation vs. free stimulation 5.026 < .001 0.638 836.428
Unpleasantness
Set stimulation vs. free stimulation 0.766 < .001 0.447 0.173
aBonferroni-corrected p = .017.
https://doi.org/10.1371/journal.pone.0223848.t003
Fig 3. Experiment 2. Mean scores of root mean square of successive differences (RMSSD). Scores during different stimulation methods at three time
measurement points. Error bars represent confidence intervals (95%).
https://doi.org/10.1371/journal.pone.0223848.g003
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SD = 17.47), t(59) = 3.410, p = .001, d = 0.440. RMSSD during stimulation first half was not sig-
nificantly different from RMSSD during the second phase of the stimulation, t(59) = 0.935, p =
.354. No significant main effect of condition, F(1, 61) = 1.715, p = .195, as well as no interaction
effect of time × condition, F(1.811, 110.475) = 0.419, p = .888, for RMSSD was found. Bayes
factors (alternative/null) provided substantial evidence against the main effect of condition
(B10 = 0.129) and strong evidence against the interaction effect between condition and time
(B10 = 0.060).
Estimation of carry-over effects on RMSSD. A paired t-test was run to check if the posi-
tion of the resting phases differed from each other regarding RMSSD. RMSSD during the first
(M = 44.22, SD = 17.86) and the second resting phase (M = 44.67, SD = 17.45) did not differ
significantly from each other, t(62) = 0.78, p = .441.
Subjective responses. Perceived stimulation intensity during the free stimulation method
(M = 6.44, SD = 2.29) was significantly higher than perceived intensity during the set stimula-
tion method (M = 3.76, SD = 2.47), t(61) = 5.026, p< .001, d = 0.638, and the rated unpleasant-
ness (free: M = 5.19, SD = 2.55; set: M = 4.89, SD = 2.76) was significantly higher during the
free stimulation method, t(61) = 0.766, p< .001, d = 0.447. Neither perceived intensity nor
unpleasantness correlated with any RMSSD measurements during stimulation.
Chosen intensity during the free stimulation method. According to the one-sample t-
test, the mean stimulation intensity chosen during the free stimulation phase was significantly
higher than that set for the set stimulation phase, t(59) = 5.365, p< .001, d = 0.693. The mean
chosen stimulation intensity correlated positively with RMSSD during the free stimulation
phase (rs = .357, p = .004). A higher chosen intensity was also associated with a higher rating of
unpleasantness, rs = .583, p< .001.
Discussion of Experiment 2
In Experiment 2, RMSSD values showed a significant overall increase during the stimulation
phase compared to the resting phase, thus giving support to H1. Importantly, similar to the
results in Experiment 1, none of the different stimulation conditions significantly differed
from each other regarding RMSSD values, meaning that H3 had to be rejected. Contrary to
our expectation, the free stimulation method was perceived as stronger and more unpleasant
than the set stimulation method. H3.1, thus, had to be rejected. Since neither perceived inten-
sity nor unpleasantness correlated with any RMSSD measurements during stimulation, H3.2
and H3.3 were also rejected. It is noteworthy that higher chosen intensities in the free stimula-
tion condition were associated with higher RMSSD values.
Given the lack of differences between the stimulation conditions in Experiments 1 and 2,
we ran a third experiment to better understand the relationship between tVNS and time mea-
surements. Specifically, we were interested in investigating if the overall increase in RMSSD
during the stimulation conditions is in fact due to the stimulation itself or a result of other
unknown factors. For this reason, in Experiment 3 we used the active stimulation conditions
from Experiment 2 and included a set sham stimulation condition as well as a free sham stimu-
lation condition.
Experiment 3
We again expected cardiac vagal activity to increase during tVNS compared to baseline mea-
surements (H1), and the free stimulation method to evoke a higher increase in cardiac vagal
activity compared to the set stimulation method (H3). Moreover, considering the results of
Experiment 2, for Experiment 3 we hypothesized (H4) that both active stimulations would
provoke higher cardiac vagal activity (measured via RMSSD) when compared to the sham
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conditions. Consequently, we expected tVNS to affect cardiac vagal activity regardless of the
active stimulation method that was tested. Furthermore, based on the results for the subjective
ratings in Experiment 2, we expected (H4.1) the free stimulation method to be perceived as the
most intense and most uncomfortable method among both methods we deployed. Therefore,
both (H4.2) the perception of stimulation intensity and (H4.3) the reported sensation of
unpleasantness during free stimulation would be associated with a decrease in RMSSD during
this condition.
We ran a repeated measures ANOVA for RMSSD with time (resting, stimulation first half,
and stimulation second half), stimulation method (set stimulation method and free stimula-
tion method) and stimulation condition (active and sham stimulation) as factors. For subjec-
tive ratings, a Friedman test was run for perceived intensity (median) and for stimulation
unpleasantness (median) with condition (set active stimulation, set sham stimulation, free
active stimulation, free sham stimulation) as a nonnormally distributed within-subject factor,
with Wilcoxon tests for post hoc analyses. The average chosen stimulation intensity in the free
active stimulation condition was M= 2.5 mA (SD = 0.93), whereas for free sham stimulation it
was M= 2.76 mA (SD = 1.01). Sixty participants took part in Experiment 3 (31 females, Mage
of 23.62 years).
Results
Cardiac vagal activity. Descriptive statistics for RMSSD and for the subjective variables
can be seen in Table 1 and results of the hypothesis testing can be found in Table 4. For
RMSSD, a repeated measures ANOVA showed a main effect of time, F(2, 118) = 5.665, p =
.004, ηp
2 = .088. Pairwise comparisons (Bonferroni-corrected p = .017) showed a nonsignifi-
cant increase from resting RMSSD (M = 61.64, SD = 23.57) to RMSSD during the first half of
the stimulation period (M = 63.79, SD = 25.20), t(59) = 2.172, p = .034, but a significant one to
RMSSD in the second half (M = 65.19, SD = 26.90), t(59) = 3.080, p = .003, d = 0.398. RMSSD
in the first half was not significantly different from RMSSD during the second half, t(59) =
1.350, p = .182. There was neither a main effect of stimulation condition, F(3, 177) = 0.031, p =
.860 (Fig 4A), nor of stimulation method, F(3, 177) = 0.948, p = .334, and no interaction effect,
F(4.766, 281.217) = 0.276, p = .759 (Fig 4B). Bayesian statistics were run for the null results and
the estimated Bayes factors (alternative/null) strongly supported the lack of main effect for
stimulation condition (B10 = 0.096), and substantially supported it for stimulation method
(B10 = 0.149), and for the lack of interaction effect (B10 = 0.125).
Estimation of carry-over effects on RMSSD. A univariate repeated measures ANOVA
was run to check if the position of the resting phases differed from each other regarding
RMSSD. Overall, RMSSD during the different resting phases differed significantly from each
other, F(2.578, 152.125) = 16.020, p< .001, ηp2 = 0.214. Six post hoc analyses were done (Bon-
ferroni-corrected p = .008). No significant difference between the resting RMSSD values in the
first and the second positions could be found, t(59) = 0.999, p = .322. However, we found a sig-
nificant increase from resting RMSSD in the first position, i.e. the resting phase before the first
condition (M = 56.77, SD = 23.94), to resting RMSSD in the third position (M = 66.04,
SD = 29.12), t(59) = 4.313, p< .001, d = 0.557, and to resting RMSSD in the fourth position
(M = 67.83, SD = 29.94), t(59) = 5.005, p< .001, d = 0.646. Resting RMSSD increased signifi-
cantly from the second position (M = 57.50, SD = 22.10) to the third one, t(59) = 3.814, p<
.001, d = 0.492, and to the fourth one, t(59) = 5.125, p< .001, d = 0.662. No significant differ-
ence between the resting RMSSD values in the third and the fourth positions could be found, t
(59) = 1.077, p = .286.
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Subjective responses. With respect to subjective responses, a Friedman test indicated that
the ratings of the stimulation intensities during the different stimulation conditions were sig-
nificantly different, χ2(3) = 81.34, p< .001. Six post hoc analyses (p = .008 after Bonferroni
correction) showed that set active stimulation (Mdn = 1.77) was rated as significantly weaker
than free active stimulation (Mdn = 6.50), z = 5.74, p< .001, r = .741, and free sham stimula-
tion (Mdn = 6.22), z = 6.57, p< .001, r = .848. Set sham stimulation (Mdn = 1.96) was per-
ceived as significantly weaker than free active stimulation, z = 5.18, p< .001, r = .669, and free
sham stimulation, z = 5.80, p< .001, r = .749. Perceived intensity correlated with no RMSSD
measurements during stimulation.
In a similar vein, regarding unpleasantness, it was shown that participants in the stimula-
tion conditions differed significantly in their estimations, χ2(3) = 29.030, p< .001. Post hoc
analyses with Wilcoxon tests (Bonferroni-corrected p = .008) indicated that free active stimula-
tion (Mdn = 3.94) was rated as significantly more unpleasant than set active stimulation
(Mdn = 1.46), z = 4.03, p< .001, r = .520, and set sham stimulation (Mdn = 1.98), z = 3.91, p<
.001, r = .505. Free sham stimulation (Mdn = 3.133) was perceived as significantly more
unpleasant than set active stimulation, z = 4.25, p< .001, r = .549, and set sham stimulation,
z = 3.82, p< .001, r = .493. Perceived intensity and unpleasantness correlated with no RMSSD
measurements during stimulation.
Chosen intensity during the free stimulation method. Two one-sample t-tests (Bonfer-
roni-corrected p = .025) revealed that the mean stimulation intensity chosen during the free
Table 4. Results of repeated-measures analysis of variance for the root mean square of successive differences (RMSSD), with Bayesian analysis (B10) as well as post
hoc tests for time measurement and for the subjective variables (Experiment 3).
RMSSD F-value p-value ηp2 B10
Stimulation condition 0.031 .860 0.096
Stimulation method 0.948 .334 0.149
Time measurements 5.665 .004 0.088 1.09
Condition x method x time 0.276 .759 0.125
Time measurements (RMSSD) t-value p-valuea Cohen’s d B10
Resting vs. stimulation 1st half 2.172 .034 1.246
Resting vs. stimulation 2nd half 3.080 .003 0.280 9.642
Stimulation 1st half vs. 2nd half 1.350 .182 .334
Perceived intensity z-value p-valueb r-value B10
Set active vs. set sham 0.184 .854 0.142
Set active vs. free active 5.740 < .001 0.741 1.140�108
Set active vs free sham 6.570 < .001 0.848 4.458�1012
Set sham vs. free active 5.180 < .001 0.669 2.068�106
Set sham vs. free sham 5.800 < .001 0.749 7.822�109
Free active vs. free sham 0.501 .617 0.154
Unpleasantness
Set active vs. set sham 0.532 .594 0.159
Set active vs. free active 4.040 < .001 0.520 386.451
Set active vs free sham 4.254 < .001 0.505 100.497
Set sham vs. free active 3.909 < .001 0.549 66.406
Set sham vs. free sham 3.823 < .001 0.494 274.774
Free active vs. free sham 1.108 .268 0.184
aBonferroni-corrected p = .017.
bBonferroni-corrected p = .008.
https://doi.org/10.1371/journal.pone.0223848.t004
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Fig 4. Experiment 3. Mean scores of root mean square of successive differences (RMSSD). Scores during (a) different stimulation
conditions as well as (b) different stimulation methods at three time measurement points. Error bars represent confidence intervals
(95%).
https://doi.org/10.1371/journal.pone.0223848.g004
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active stimulation phase was significantly higher than that set for the set active stimulation
phase, t(59) = 12.141, p< .001, d = 1.567, and that the mean stimulation intensity chosen dur-
ing the free sham stimulation phase was significantly higher than that set for the set sham stim-
ulation phase, t(59) = 13.542, p< .001, d = 1.748. The mean stimulation intensity chosen
during the free active stimulation phase was significantly lower than that chosen during the
free sham stimulation phase, t(59) = 2.501, p = .015, d = 0.323. Chosen stimulation intensity
was not correlated with RMSSD during the free active and free sham stimulation phases. Like-
wise, chosen intensity in both free stimulation conditions was not correlated with perceived
stimulation intensity and with the rating of unpleasantness in the respective phases.
Discussion of Experiment 3
In line with Experiments 1 and 2, in Experiment 3 we found an increase from resting RMSSD
to the RMSSD values during the stimulation phase, thus giving support to H1. Against H3, the
effects of different stimulation methods on RMSSD did not differ from each other. Surpris-
ingly, there was no difference between the active and sham conditions, meaning that H4 had
to be rejected. Moreover, contrary to Experiments 1 and 2, there was evidence for a carry-over
effect between the second and the third condition. The rated strength of the stimulation inten-
sities within the stimulation conditions corresponded to the real stimulation intensities. In line
with our expectations (H4.1), the stimulation intensities that could be chosen freely were per-
ceived as higher than the set stimulation intensity 1.0 mA and were also rated as more unpleas-
ant. Contrary to the results in Experiment 2 and to our expectations, in Experiment 3 the
perception of stimulation intensity (H4.2) and the reported sensation of unpleasantness (H4.2)
during the free stimulation condition were not associated with higher RMSSD values.
General discussion
We investigated the influence of tVNS on cardiac vagal activity by testing the effect of different
stimulation intensities on a vagally-mediated HRV parameter as well as on subjective ratings.
This was the first study on tVNS to systematically investigate the effects of different stimulation
intensities and different methods to determine them on cardiac vagal activity. The outcomes
of the three experiments regarding effects of tVNS on cardiac vagal activity followed the same
pattern, namely an increase in cardiac vagal activity from resting to at least one of the stimula-
tion phases. However, this increase was general and thus not dependent on the different stimu-
lation intensities or methods used to determine them, including the comparison between
active and sham stimulation. This pattern of results was solidly supported by Bayesian estima-
tions. On the subjective level, higher stimulation intensities were perceived as stronger, and
the free stimulation method was perceived as stronger than the set stimulation method (Exper-
iments 2 and 3). A stronger stimulation was generally also perceived as more unpleasant. Only
in Experiment 1 a subjective rating of stimulation intensity or method correlated with
RMSSD, namely the rating during the 1.5 mA-condition. Importantly, in Experiment 3 we
found no differences between active and sham stimulations regarding cardiac vagal activity
and this is in accordance with previous research [27–29,45]. Besides a rather unlikely potential
placebo effect due to the single-blind design, we can think of two further possible explanations
for this lack of differences. First, it is possible that stimulation parameters of tVNS do not affect
its underlying mechanisms of action. In pain research, it has been speculated that VNS could
send non-specific signals at the brainstem level. According to this idea, these signals would
compete with incoming pain stimuli or alternatively trigger non-specific reflexes that activate
pain inhibition, for instance by means of release of inhibitory neurotransmitters [46]. If this is
also the case for the vagal pathway that is responsible for affecting cardiac activity, the effect of
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tVNS would be independent of its stimulation parameters (including the differentiation
between active and sham stimulation), as long as the electrical signal evoked by tVNS reaches
the brainstem nuclei involved.
Second, the suitability of the earlobe as a sham condition has been questioned. Peuker and
Filler [7] offered a detailed description of the nerve distribution of different innervation areas
of the human auricle, showing that the earlobe is free from vagal innervation and has the great
auricular nerve as its only source of innervation. However, their findings were based on a sam-
ple of only seven human cadavers and in general, they also lacked substantial evidence that
electrical stimulation on the earlobe cannot stimulate brain center nuclei that trigger an
increase in cardiac vagal outflow [47]. Different fMRI studies [24,25,48] found evidence of
activation of vagal pathways during tVNS when compared to earlobe stimulation; however,
active stimulation was not always applied on the left cymba conchae. Furthermore, stimulation
parameters such as the on–off cycles, differed partially from those in the present study [25].
This showcases once again that the lack of standards is an issue in tVNS research. Future stud-
ies should systematically address this topic by comparing areas that are currently being used as
stimulation areas on the ear, such as the cymba conchae, outer auditory canal, and tragus, with
stimulation on the earlobe using a multi-method approach—that is, taking behavioral and
physiological measures into account.
Third, despite an increase of cardiac vagal activity from before to during tVNS and given
that other reasons for this increase besides the action of tVNS cannot be completely ruled out,
it is possible that RMSSD, as a marker of cardiac vagal activity, is not sensitive to afferent vagal
changes triggered by tVNS. Since the tVNS signal on the left auricular branch of the vagus
nerve is afferently sent to the prefrontal cortex, from where the signal is expected to go effer-
ently to the heart [49], it is so far not clear if the electrical signal produced by tVNS is strong
enough to overcome body-related barriers such as skin and blood vessels and therefore trigger
vagal afferent firing in a way that would robustly increase prefrontal activity. This question
may also be related to individual differences that can be relevant regarding electrical stimula-
tion: Skin properties such as impedance, water content, structure, and subcutaneous fat thick-
ness for instance have been shown to have an influence on the efficacy of transcutaneous
electrical stimulation [50,51] and may have an influence on the response to tVNS. For this rea-
son, to increase explained variance of the results, we recommend that future studies control
for skin characteristics as well as further anatomical individual differences in the ear–fat thick-
ness, for instance, is often measured using ultrasonography [50]. Some of these interindividual
differences concerning skin characteristics can be related to age; specifically, older age is
related to dryer, thinner and less hydrated skin and this can influence the sensibility to electri-
cal transcutaneous stimulation [52]. Therefore, in case the sample consists of a heterogeneous
population (in contrast to student samples), it is reasonable to take this potential confounder
into account in the data analyses. Future studies should also address some of these questions
by testing tVNS in combination with HRV and neuroimaging techniques such as fMRI and
functional near-infrared spectroscopy (fNIRS), especially when it comes to investigating the
sensitivity of cardiac vagal activity as a marker of vagal activation through tVNS. In these stud-
ies, a double-blind design should be considered to avoid possible placebo effects occurring
with the sham stimulations.
Another noteworthy finding in the present study is that the stimulation intensities that
were chosen on average in the free stimulation method were higher than the intensity normally
reported in the tVNS literature [24,27,47]. A possible explanation is that most participants in
the sample were sport students, which may have led to a sample with more participants with
an inclination to be competitive. Competitiveness may explain why the participants often
tended to choose stimulation intensities that were reported as uncomfortable without the
Influence of transcutaneous vagus nerve stimulation intensity on cardiac vagal activity
PLOS ONE | https://doi.org/10.1371/journal.pone.0223848 October 11, 2019 17 / 23
existence of an apparent reward in the present study. Future studies should investigate the
influence of different participants’ backgrounds on the outcomes related to tVNS and also use
more standardized methods to determine the individual stimulation intensity, similar to other
recent studies with tVNS [17,18].
Considering the previous literature on VNS [53], we expected the effects of short-term
tVNS to be transient and to be confined to the stimulation periods. However, although analy-
ses of carry-over effects on RMSSD at the resting phases provided evidence against the exis-
tence of carry-over effects in Experiments 1 and 2, an evidence for a carry-over effect in
Experiment 3 was found. This interpretation comes from the results that the resting positions
in Experiments 1 and 2 did not show any increase regarding RMSSD, whereas there was a sig-
nificant increase between the first two resting phases and the last two resting phases in Experi-
ment 3. Since Experiment 3 was the longest one among the three experiments and had the
highest number of conditions (and consequently of stimulation periods), it is possible that a
longer or more frequent stimulation plays a role when it comes to cardiac vagal effects of
tVNS. Thus, the question related to the duration of tVNS effects still has to be further investi-
gated. In a previous study, no relation was found between order of condition and HRV levels
in the context of an experiment that lasted about 65 minutes, although it is not clear how
exactly this was evaluated [27]. Nonetheless, it should be highlighted that the idea that tVNS
has a transient effect comes from a previous VNS study [53] in which first, brain norepineph-
rine concentrations were measured and not cardiac vagal activity and second, the authors used
(cervical) invasive vagus nerve stimulation in rats. Concerning tVNS, so far there is scarce evi-
dence that a majority of brain areas that are thought to be part of the vagal pathway remain
active after cessation of the stimulation of the left cymba conchae, although some areas con-
tinue to be active up to 11 minutes after stimulation [24]. Even though this finding lacks any
inferential statistical analysis, it shows the importance of systematically taking into account the
duration of effects after the stimulation period before drawing conclusions. Whether the
effects of tVNS are transient is a question that should be specifically addressed by systemati-
cally comparing different time settings and stimulating the auricular branch of the vagus
nerve, using cardiac vagal activity as a dependent variable and comparing its measurement
before, during, and after the stimulation.
The same is valid for the often-discussed idea that the mechanism behind tVNS is related to
the Yerkes–Dodson principle [36]: no evidence towards an inverted U-shaped curve could be
found in the present study. Even if we used similar stimulation intensities as found in a previ-
ous study with humans receiving invasive VNS [38], it is important to highlight that this previ-
ous study investigated memory instead of cardiac vagal activity. Given the lack of outcome
comparability, it is not possible to infer that the intensities that have been used correspond in
fact to low, intermediary and high intensities, respectively. In the opposite direction, it is also
possible that all intensities, especially in Experiment 1, are situated in the first, upward phase
of the inverted U-shaped curve. Consequently, given this pattern could not be observed in the
present study, its existence regarding the relationship between tVNS and cardiac vagal activity
remains speculative. Future studies should further investigate this important issue by consider-
ing the points raised above and also address other domains that are thought to be modulated
by tVNS, such as physiological (e.g. pupillary responses [54,55]) and cognitive processes (e.g.
working memory and inhibitory control [3]).
Limitations
The main limitation of our study was that we did not to take different physiological markers
into account to compare them with cardiac vagal activity measurements, nor used
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neuroimaging techniques such as fMRI or fNIRS. Possible additional markers could be mea-
surements of neurotransmitters thought to be linked to tVNS, for example, salivary alpha amy-
lase, pupillary responses or P300 for norepinephrine release [18,56], or markers for
sympathetic activity such as preejection period [57] and muscle sympathetic nerve activity
[26]. Further, choosing to test all conditions in the same session may have led to some carry-
over effects, as stated above. Moreover, respiration was not measured. Effects on RMSSD may
be driven by influences of tVNS upon respiration, meaning that if an intervention can make
persons breathe more slowly, RMSSD might in turn be increased [58]. Regarding the subjec-
tive responses, the formulation of the questions may have influenced the responses, since the
question for measuring perceived intensity described a specific sensation provoked by tVNS (a
tingle in the ear) whereas the unpleasantness question does not use such descriptive word for
the stimulation sensation. Finally, although this was not the focus of the present study, a limita-
tion may be that we did not take a cognitive paradigm into account, which would have enabled
us to investigate the role of tVNS compared to sham stimulation as a moderator of cognitive
functioning.
Conclusions
The present study was the first attempt to systematically investigate, at the physiological and
subjective level, the effects of different tVNS stimulation intensities as well as different stimula-
tion methods. Based on the results summarized above, further investigation is needed on the
potential effect of tVNS on cardiac vagal activity. Furthermore, the findings reported here
revealed the importance of performing Bayesian analyses in addition to classical inferential
hypothesis testing. Finally, this study pointed out the challenges in current research on tVNS
and the need to address the lack of standards for stimulation to be used in cognitive and physi-
ological studies.
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